We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Committee Recommends Withdrawal of AMAG’s Preterm Birth Drug
FDA Advisory Committee Recommends Withdrawal of AMAG’s Preterm Birth Drug
An FDA advisory committee voted on Tuesday to support withdrawal of FDA approval for AMAG Pharmaceuticals’ preterm birth injection Makena (hydroxyprogesterone caproate).